• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume10, Issue1

Vaccines and Comorbidities: Balancing Risks and Benefits

    Baijnath Das, Dr. Ruchi Kant, Shreelata Mandal, Dr. Navneet Kumar

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 1, Pages 5273-5281

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Vaccines have long been viewed as one of the most successful treatments in the history of public health.[1] They have helped to the elimination of various illnesses, including smallpox.[1,2] Vaccine hesitancy, or rejection or delay in immunisation, remains a substantial public health concern despite the obvious advantages of vaccination.[3]Vaccines date back to the 10th century when the Chinese started utilising variolation, a procedure in which material from smallpox abscesses was used to enter a healthy individual to prevent smallpox.[4] Even though this approach provided some protection for the illness, it was very dangerous and may have led to death or serious complications.[5] The modern age of vaccinations started with the efforts of Edward Jenner, who employed cowpox to produce protection against smallpox in the late 18th century. [5,6] This procedure, known as vaccination, was far safer than variolation and laid the groundwork for creating contemporary vaccinations. [5-7] Vaccines were produced throughout the following two centuries for various infectious illnesses, including measles, rubella, diphtheria, and polio. [7,8] These immunisations have reduced infectious disease-related morbidity and death
Keywords:
  • PDF (274 K)
  • XML
(2023). Vaccines and Comorbidities: Balancing Risks and Benefits. European Journal of Molecular & Clinical Medicine, 10(1), 5273-5281.
Baijnath Das, Dr. Ruchi Kant, Shreelata Mandal, Dr. Navneet Kumar. "Vaccines and Comorbidities: Balancing Risks and Benefits". European Journal of Molecular & Clinical Medicine, 10, 1, 2023, 5273-5281.
(2023). 'Vaccines and Comorbidities: Balancing Risks and Benefits', European Journal of Molecular & Clinical Medicine, 10(1), pp. 5273-5281.
Vaccines and Comorbidities: Balancing Risks and Benefits. European Journal of Molecular & Clinical Medicine, 2023; 10(1): 5273-5281.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 23
  • PDF Download: 49
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus